Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone ER for Sleep Architecture in Schizophrenia
NCT00105326Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Feb 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of paliperidone in schizophrenia, Insomnia, sponsored by Johnson & Johnson. Started Feb 2005; status: completed.
02
Drugs
paliperidone
03
Conditions
schizophreniaInsomnia
Beyond the preview
Go deeper on NCT00105326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00105326.